Harsha P. Gunawardena

Johnson & Johnson (United States)

Papers

1

Total Citations

24

H-Index

1

About

Harsha P. Gunawardena is a leading figure in biopharmaceutical mass spectrometry, driving innovation in high-throughput automation for therapeutic protein characterization. His seminal work, “Lab of the Future─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics” (2023), with 24 citations, describes a groundbreaking integrated platform combining liquid handling robotics, microplate automation, and LC-MS with advanced data analysis software. This system revolutionizes the characterization of biotherapeutics by enabling unattended, high-throughput workflows that dramatically accelerate drug development timelines. Gunawardena’s contributions address critical bottlenecks in the pharmaceutical industry, bridging the gap between manual, labor-intensive methods and fully automated, reproducible processes. His work has significant impact on quality control and regulatory compliance for biologic drugs, earning recognition for its practical, scalable design. By pioneering the “Lab of the Future” concept, Gunawardena has established a new standard for efficiency and precision in biotherapeutic analysis, making him a key innovator in the field of analytical biotechnology.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
“Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics
24 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago